# Initiate Phase 2 study in women with postpartum depression (PPD) in 1H 2017
# Report top-line data from children with genetic seizure disorders in mid-2017
# Initiate Phase 2 study in patients with status epilepticus (SE) in 2H 2017
"At March 31, 2017, the Company had cash, cash equivalents and investments of $24.8 million, compared to $30.1 million at December 31, 2016. The Company believes that its cash, cash equivalents and investments, as of March 31, 2017, are adequate to fund operations into the second half of 2018".
Trading at Cash On Hand.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.